Coronavirus Disease 2019

0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

HM
Hua MedicineChina - Shanghai
1 program
Neurologic Manifestations of COVID-19N/A1 trial
Active Trials
NCT04386083Unknown1,342Est. Mar 2021
Verona Pharma
Verona PharmaUK - London
1 program
not applicableN/A1 trial
Active Trials
NCT04497194Completed430Est. Sep 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Hua MedicineNeurologic Manifestations of COVID-19
Verona Pharmanot applicable

Clinical Trials (2)

Total enrollment: 1,772 patients across 2 trials

NCT04386083Hua MedicineNeurologic Manifestations of COVID-19

Neurologic Manifestations of COVID-19

Start: Jun 2020Est. completion: Mar 20211,342 patients
N/AUnknown
NCT04497194Verona Pharmanot applicable

Registry of COVID-19 Patients at AOUI Verona

Start: Mar 2020Est. completion: Sep 2020430 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space